
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Upcoming Result Date: Jan 27, 2026
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Kaya Ltd (KAYA) is currently trading at 368.45 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Kaya Limited is a leading player in aesthetic dermatology, operating a vast network of skin care clinics under the 'Kaya' brand in India and the Middle East. In the latest quarter, Kaya reported a modest revenue growth of 1% year-on-year, with a notable 7% collection growth in its clinic business, primarily driven by Bath and Body, Nutraceuticals, and Sun Care categories. The company launched two new clinics in Bangalore and Noida, as part of its expansion efforts, further bolstering its presence in India. Kaya's loyalty program, Kaya Smiles, significantly contributes over 90% to clinic collections, underscoring the importance of repeat business and customer loyalty in their strategy.
Over the past 52 weeks, Kaya Ltd has traded between a low of ₹213.50 and a high of ₹486.90. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Kaya Ltd has a market capitalization of approximately 581.00. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Kaya Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of N/A and operates in the Healthcare sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
You can buy shares of Kaya Ltd (KAYA) through any SEBI-registered stockbroker in India. A demat and trading account are required to place buy or sell orders on stock exchanges such as NSE or BSE. Shares are credited to the demat account as per the exchange settlement cycle.
Based on its market capitalization of 581.00 Cr, Kaya Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Kaya Ltd operates in the Healthcare sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Kaya Ltd is N/A. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Kaya Ltd currently does not pay dividends. Companies that do not pay dividends often reinvest profits to support business growth or strengthen operations.
Key risks associated with Kaya Ltd include sector-specific challenges in the Healthcare industry, regulatory changes, competitive pressures, company-level financial performance, overall market volatility, and broader macroeconomic factors that can impact stock prices.
Investor Presentation
Q1 FY26
Investor Presentation
Q4 FY25
Investor Presentation
Q3 FY25
Investor Presentation
Q2 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q1 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY24
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY24
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY24
Bearish
3
Neutral
8
Bullish
3
Bearish
35
Neutral
8
Bullish
3
Bearish
32
Neutral
0
Bullish
0

Market Cap
₹ 581 Cr
P/E
—
Healthcare
Personal Care - Indian - Medium / Small
581 Cr
High Risk
—
273.8
—
—
486.90
213.50
Sales CAGR
1Y
5.84%
3Y
15.56%
5Y
1.25%
10Y
1.79%
Profit CAGR
1Y
164.54%
3Y
—
5Y
—
10Y
—
ROE
TTM
59.93%
3Y
34.52%
5Y
64.71%
10Y
-65.09%
ROCE
TTM
-12.08%
3Y
-66.89%
5Y
-39.13%
10Y
-15.28%
Performance
STEADY PERFORMER
Valuation
REASONABLE
Growth
STABLE
Profitability
LOW MARGIN
Technicals
Bearish
Risk
MODERATE RISK